Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...
Taking steps to lower levels of harmful LDL cholesterol at a much earlier stage than current medical practice indicates could ...
European Commission approval expands the indication of lomitapide in the European Union (EU) to include children 5 years of ...
A groundbreaking gene therapy, VERVE-102, has shown promise in reducing "bad" cholesterol by up to 62% with a single ...
The VERVE-102 base editor appeared to be safe and reduce low-density lipoprotein cholesterol levels by up to 62 percent in a Phase I open-label, single-ascending dose trial.
This drink could help lower your risk of heart attacks and strokes when consumed as part of a healthy, balanced diet ...
A new study explores the cholesterol-lowering effects of a new drug called enlicitide. Nicole Mason/Stocksy A recent study, published in JAMA on November 9, investigates a drug called enlicitide. The ...
A recent study published in Engineering has shed new light on the relationship between cholesterol levels and mortality risks. The research, conducted by a team of scientists from multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results